{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T13:10:53Z","timestamp":1789823453491,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1K08EB038393"],"award-info":[{"award-number":["1K08EB038393"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005831","name":"Foundation for Anesthesia Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005831","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bjaopen.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BJA Open"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bjao.2026.100567","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:59:30Z","timestamp":1781726370000},"page":"100567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rethinking remimazolam: reconciling regulatory positioning with clinical reality"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7149-9150","authenticated-orcid":false,"given":"Theodora","family":"Wingert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3546-9856","authenticated-orcid":false,"given":"J. Robert","family":"Sneyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjao.2026.100567_bib1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s44254-023-00021-7","article-title":"Remimazolam \u2013 current status, opportunities and challenges","volume":"1","author":"Sneyd","year":"2023","journal-title":"Anesthesiol Perioper Sci"},{"key":"10.1016\/j.bjao.2026.100567_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4236\/ojanes.2025.1512022","article-title":"five years of clinical experience since its first-in-world approval in Japan","volume":"15","author":"Remimazolam","year":"2025","journal-title":"Open J Anesthesiol"},{"key":"10.1016\/j.bjao.2026.100567_bib3","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics","volume":"115","author":"Antonik","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bjao.2026.100567_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1213\/ANE.0b013e318241f68a","article-title":"A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation","volume":"115","author":"Wiltshire","year":"2012","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bjao.2026.100567_bib5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.gie.2015.08.062","article-title":"A phase IIb study comparing the safety and efficacy of remimazolam and midazolam in patients undergoing colonoscopy","volume":"83","author":"Pambianco","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bjao.2026.100567_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/bja\/70.4.423","article-title":"Comparison of infusion rates of three i.v. anaesthetic agents for induction in elderly patients","volume":"70","author":"Berthoud","year":"1993","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2026.100567_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","article-title":"Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial","volume":"34","author":"Doi","year":"2020","journal-title":"J Anesth"},{"key":"10.1016\/j.bjao.2026.100567_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/bja\/aeu313","article-title":"5th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors","volume":"113","author":"Pandit","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2026.100567_bib9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1399-6576.1982.tb01817.x","article-title":"Intravenous benzodiazepines as anaesthetic agents: pharmacokinetics and clinical consequences","volume":"26","author":"Kanto","year":"1982","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.bjao.2026.100567_bib10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s40262-025-01548-7","article-title":"Clinical pharmacokinetics and pharmacodynamics of remimazolam","volume":"64","author":"de Jong","year":"2025","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bjao.2026.100567_bib11","doi-asserted-by":"crossref","first-page":"6384","DOI":"10.1097\/JS9.0000000000002737","article-title":"Anesthetic efficacy with remimazolam compared with propofol: a systematic review and meta-analysis of randomized controlled trials","volume":"111","author":"Xing","year":"2025","journal-title":"Int J Surg"},{"key":"10.1016\/j.bjao.2026.100567_bib12","series-title":"NAP5 5th National Audit Project of the Royal College of Anaesthetists and the Association of Anaesthetists of Great Britain and Ireland: Accidental Awareness during General Anaesthesia in the United Kingdom and Ireland","first-page":"63","author":"Palmer","year":"2014"},{"issue":"5","key":"10.1016\/j.bjao.2026.100567_bib13","article-title":"Association between a remimazolam-propofol combination for maintenance of anesthesia and extubation time: a propensity score analysis","volume":"12","author":"Katsuragawa","year":"2025","journal-title":"JA Clin Rep"},{"key":"10.1016\/j.bjao.2026.100567_bib14","article-title":"Impact of the combination of remimazolam and volatile anesthetics on circulatory dynamics in free-flap reconstruction surgery for oral cancer: a retrospective comparison with desflurane and sevoflurane","volume":"17","author":"Sasaki","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.bjao.2026.100567_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1213\/ANE.0b013e3182a705ae","article-title":"A phase Ib, dose-finding study of multiple doses of remimazolam (CNS 7056) in volunteers undergoing colonoscopy","volume":"117","author":"Worthington","year":"2013","journal-title":"Anesth Analg"},{"key":"10.1016\/j.bjao.2026.100567_bib16","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bja.2021.04.025","article-title":"What we do, what we call ourselves, and how we spell it","volume":"127","author":"Sneyd","year":"2021","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2026.100567_bib17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bja.2018.04.016","article-title":"Cross-sectional study of perioperative drug and allergen exposure in UK practice in 2016: the 6th National Audit Project (NAP6) allergen Survey","volume":"121","author":"Marinho","year":"2018","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2026.100567_bib18","series-title":"Byfavo 50 mg powder for concentrate for solution for injection\/infusion","year":"2024"},{"key":"10.1016\/j.bjao.2026.100567_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.690875","article-title":"Remimazolam: non-clinical and clinical profile of a new sedative\/anesthetic agent","volume":"12","author":"Kilpatrick","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bjao.2026.100567_bib21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/CCM.0000000000007011","article-title":"Remimazolam besylate versus dexmedetomidine as a sedative in ICU patients undergoing mechanical ventilation: a multicenter, single-blinded, randomized, noninferiority trial","volume":"54","author":"Cheng","year":"2026","journal-title":"Crit Care Med"},{"key":"10.1016\/j.bjao.2026.100567_bib22","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/bja\/aeh086","article-title":"Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment","volume":"92","author":"Pitsiu","year":"2004","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.bjao.2026.100567_bib23","doi-asserted-by":"crossref","DOI":"10.1097\/ALN.0000000000006047","article-title":"Efficacy and safety of remimazolam tosylate versus propofol for sedation of postoperative mechanically ventilated patients in intensive care units: a multicenter, randomized, single-blind, non-inferiority, phase 3 trial","author":"Guan","year":"2026","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bjao.2026.100567_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40560-026-00849-8","article-title":"Discontinuation of the development of remimazolam for ICU sedation in Japan: background and rationale","volume":"14","author":"Saito","year":"2026","journal-title":"J Intensive Care"}],"container-title":["BJA Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772609626000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772609626000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T12:36:01Z","timestamp":1789821361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772609626000419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":23,"alternative-id":["S2772609626000419"],"URL":"https:\/\/doi.org\/10.1016\/j.bjao.2026.100567","relation":{},"ISSN":["2772-6096"],"issn-type":[{"value":"2772-6096","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking remimazolam: reconciling regulatory positioning with clinical reality","name":"articletitle","label":"Article Title"},{"value":"BJA Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjao.2026.100567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.bjao.2026.100575","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of British Journal of Anaesthesia.","name":"copyright","label":"Copyright"}],"article-number":"100567"}}